Healthcare -
Biotechnology - NASDAQ - US
$ 5.25
8.25 %
$ 111 M
Market Cap
-0.96
P/E
ENTA - TOTAL CURRENT LIABILITIES
Total Current Liabilities ENTA - Enanta Pharmaceuticals, Inc.
57.5 M
LAST VALUE
38.89%
2 YEAR CAGR
20.54%
5 YEAR CAGR
28.34%
10 YEAR CAGR